Next Article in Journal
Synthetic Medicinal Chemistry in Chagas’ Disease: Compounds at The Final Stage of “Hit-To-Lead” Phase
Next Article in Special Issue
Antiproliferative Properties of Type I and Type II Interferon
Previous Article in Journal
Implications of Inter-Individual Differences in Clopidogrel Metabolism, with Focus on Pharmacogenetics
Previous Article in Special Issue
Deregulation of Interferon Signaling in Malignant Cells
Pharmaceuticals 2010, 3(4), 795-809; doi:10.3390/ph3040795
Review

Lambda Interferons: New Cytokines with Old Functions

1
, 1,
, 2
 and 1,*
Received: 5 February 2010; in revised form: 24 March 2010 / Accepted: 24 March 2010 / Published: 25 March 2010
(This article belongs to the Special Issue Interferons)
View Full-Text   |   Download PDF [1337 KB, uploaded 25 March 2010]   |   Browse Figures
Abstract: Interferon lambda (IFN-λ) is a member of the class II cytokine family, and like the other members of this family, they are small helical proteins. Since their discovery significant efforts have been made to determine their role in innate and adaptive immunity. Their strong antiviral activity, both in vitro and in vivo, has firmly established their interferon status. However, in contrast to type I interferon, only a very limited subset of cells/tissues responds to interferon lambda. In addition to inducing an antiviral state in responsive cells, recent data suggest that IFN-l plays a role in shaping the adaptive immune response. However, the data is not in complete agreement regarding the effect of IFN-λ on the adaptive immune system. Recently IFN-l has entered clinical trials against hepatitis C Virus and IFN-l is a promising future therapeutic, against different viruses replicating in responsive tissues, like that of the airway epithelia. In this review we describe the knowledge acquired during the past six years about the structure and function of interferon lambda.
Keywords: Interferon; structure; innate immunity; adaptive immunity; antiviral activity; ISGF3; IFN-λR1 Interferon; structure; innate immunity; adaptive immunity; antiviral activity; ISGF3; IFN-λR1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Hamming, O.J.; Gad, H.H.; Paludan, S.; Hartmann, R. Lambda Interferons: New Cytokines with Old Functions. Pharmaceuticals 2010, 3, 795-809.

AMA Style

Hamming OJ, Gad HH, Paludan S, Hartmann R. Lambda Interferons: New Cytokines with Old Functions. Pharmaceuticals. 2010; 3(4):795-809.

Chicago/Turabian Style

Hamming, Ole J.; Gad, Hans Henrik; Paludan, Søren; Hartmann, Rune. 2010. "Lambda Interferons: New Cytokines with Old Functions." Pharmaceuticals 3, no. 4: 795-809.


Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert